N-Acetylcysteine for Health & Longevity - Quick Reference Sheet

N-Acetylcysteine for Health & Longevity

Created on 10/09/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Sonnet 5.5 – Audit

N-acetylcysteine is a modified amino acid sold as an oral supplement and a hospital drug for acetaminophen overdose and thinning airway mucus. The body converts it into a building block of its own antioxidant. For longevity-oriented adults, evidence of broader benefit is thin and conflicting; lifespan evidence is animal-only. Side effects are mostly mild and digestive; injected use and nitroglycerin combinations carry stronger concerns. (Full Review)

Protocol

Supplement-community range
600–1,800 mg daily
In divided doses; 300 mg to 6 g daily studied
Respiratory and immune regimen
600 mg twice daily
1,200 mg/day; used for lung-disease exacerbations and, for six months, influenza-like illness
Half-life and splitting
Two or three daily doses
Terminal half-life near 5.6 hours; the trials used divided doses
Time to effect
Symptom trials
6–12 months
Duration of influenza-like illness and Parkinson's disease symptom trials
Low-glutathione adults
30 days
Improved exercise performance in one small trial
Healthy older adults
No rise at 2 weeks
No glutathione increase observed after two weeks

Benefits

Contraindications
  • Known hypersensitivity (allergy) to acetylcysteine
  • Nitrate use (nitroglycerin, isosorbide mononitrate) without blood-pressure monitoring (theoretical for oral doses)
  • Asthma: avoid inhaled forms without supervision
  • Pregnancy and breastfeeding (theoretical caution)
Key Interactions
  • Blood-pressure medications (lisinopril, amlodipine, losartan): monitor (theoretical)
  • Anticoagulants and antiplatelets (blood-clot-preventing drugs: warfarin, apixaban, clopidogrel, aspirin): monitor (theoretical)
  • Activated charcoal: avoid co-administration
  • Cough suppressants (dextromethorphan, codeine): caution (theoretical)
  • Other glutathione precursors and antioxidants (glycine, alpha-lipoic acid, vitamin C, vitamin E): caution (theoretical)
  • Blood-pressure-lowering supplements (beetroot nitrate, L-arginine, L-citrulline): monitor (theoretical)

Risk & Side Effects

  • High:
  • Medium: Amplified nitroglycerin effects
  • Low: Gastrointestinal upset and headache; allergy-like and airway reactions
  • Speculative: Tumor growth and spread in mouse models; accelerated aging with chronic thiol dosing in worms

Monitoring

Marker Target Why
Whole-blood total glutathione No established target; track change from own baseline Marker the intervention is expected to change
Reduced-to-oxidized glutathione ratio No established target; track change from own baseline Expected-to-change marker of redox balance
Malondialdehyde No established target; track change from own baseline Expected-to-change marker of lipid damage
Blood pressure No established target; track seated readings against own baseline Safety check: amplified nitroglycerin effects

Cadence: 2 weeks, 3 months, then every 6–12 months, repeating the same measures under the same conditions

Qualitative Assessment

  • Frequency and severity of colds or influenza-like illnesses
  • Respiratory exacerbations and mucus symptoms
  • Mood and anxiety ratings
  • Exercise recovery and muscle soreness
  • Gastrointestinal tolerance and headaches